Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct;24(10):1112-20.
doi: 10.1111/j.1464-5491.2007.02202.x. Epub 2007 Aug 2.

A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets

L M G Steuten  1 , H J M Vrijhoef, S Landewé-Cleuren, N Schaper, G G Van Merode, C Spreeuwenberg
Affiliations

A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets

L M G Steuten et al. Diabet Med. 2007 Oct.

Abstract

Aim: To assess the impact of a disease management programme for patients with diabetes mellitus (Type 1 and Type 2) on cost-effectiveness, quality of life and patient self-management. By organizing care in accordance with the principles of disease management, it is aimed to increase quality of care within existing budgets.

Methods: Single-group, pre-post design with 2-year follow-up in 473 patients.

Results: Substantial significant improvements in glycaemic control, health-related quality of life (HRQL) and patient self-management were found. No significant changes were detected in total costs of care. The probability that the disease management programme is cost-effective compared with usual care amounts to 74%, expressed in an average saving of 117 per additional life year at 5% improved HRQL.

Conclusion: Introduction of a disease management programme for patients with diabetes is associated with improved intermediate outcomes within existing budgets. Further research should focus on long-term cost-effectiveness, including diabetic complications and mortality, in a controlled setting or by using decision-analytic modelling techniques.

PubMed Disclaimer